Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Sflomos

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oncotarget|August 3, 2013
A new Achilles Heel in breast cancer?George Sflomos, Cathrin Brisken
Journal of Visualized Experiments : Jove|January 16, 2015
An ex vivo model to study hormone action in the human breastGeorge Sflomos, Marie Shamsheddin, Cathrin Brisken
Endocrine-Related Cancer|March 23, 2018
The challenges of modeling hormone receptor-positive breast cancer in miceBerna C Özdemir, George Sflomos, Cathrin Brisken
Endocrinology|March 29, 2024
Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?Renée L Flaherty, George Sflomos, Cathrin Brisken
Biochemical and Biophysical Research Communications|August 3, 2005
The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding proteinZoe Karetsou, Goran Martic, George Sflomos, et al.
NPJ Breast Cancer|March 15, 2026
Preclinical models of breast cancer metastasis: strengths, limitations, and clinical relevancePatrick Aouad, Karim Halabi, Berthe Hayar, et al.
Cancers|July 14, 2023
Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast CarcinomaGeorge Sflomos, Nora Schaumann, Matthias Christgen, et al.
Journal of Cell Science|September 1, 2011
ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBINGeorge Sflomos, Eleftherios Kostaras, Ekaterini Panopoulou, et al.
Nature Communications|November 11, 2018
Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epitheliumStéphanie Cagnet, Dalya Ataca, George Sflomos, et al.
The Journal of Pathology|November 16, 2018
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesionsMaryse Fiche, Valentina Scabia, Patrick Aouad, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oncotarget|August 3, 2013
A new Achilles Heel in breast cancer?George Sflomos, Cathrin Brisken
Journal of Visualized Experiments : Jove|January 16, 2015
An ex vivo model to study hormone action in the human breastGeorge Sflomos, Marie Shamsheddin, Cathrin Brisken
Endocrine-Related Cancer|March 23, 2018
The challenges of modeling hormone receptor-positive breast cancer in miceBerna C Özdemir, George Sflomos, Cathrin Brisken
Endocrinology|March 29, 2024
Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?Renée L Flaherty, George Sflomos, Cathrin Brisken
Biochemical and Biophysical Research Communications|August 3, 2005
The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding proteinZoe Karetsou, Goran Martic, George Sflomos, et al.
NPJ Breast Cancer|March 15, 2026
Preclinical models of breast cancer metastasis: strengths, limitations, and clinical relevancePatrick Aouad, Karim Halabi, Berthe Hayar, et al.
Cancers|July 14, 2023
Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast CarcinomaGeorge Sflomos, Nora Schaumann, Matthias Christgen, et al.
Journal of Cell Science|September 1, 2011
ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBINGeorge Sflomos, Eleftherios Kostaras, Ekaterini Panopoulou, et al.
Nature Communications|November 11, 2018
Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epitheliumStéphanie Cagnet, Dalya Ataca, George Sflomos, et al.
The Journal of Pathology|November 16, 2018
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesionsMaryse Fiche, Valentina Scabia, Patrick Aouad, et al.
Pageof 3